Geisinger successfully discharges 500th patient with COVID-19

As Geisinger continues reopening its clinics and welcoming patients and members back for procedures, the health system is announcing the successful discharge of more than 500 patients who were treated for COVID-19 across its Pennsylvania hospitals, including 12 patients from Geisinger Jersey Shore Hospital.

Of those more than 500 patients, about 150 of them spent time in one of Geisinger’s intensive care units. More than 95 of them were on ventilators and transitioned off during their hospital stay.

“As a large health system, we’re fortunate to have a dedicated staff and resources to provide a high level of care to our communities,” said J. Edward Hartle, M.D., Geisinger executive vice president and chief medical officer. “The staff’s effort during these challenging times is inspiring and we’re grateful for their commitment to meeting the health needs of our patients, members and communities now and into the future.”

Geisinger’s clinical efforts were led by a multidisciplinary team that meets regularly to review and adapt treatments for patients with COVID-19. In addition, Geisinger leveraged its specialized programs and staff to provide care options not widely available in its communities.

Innovative solutions like ECMO, which isn’t a treatment specific for COVID but can help when a ventilator is no longer sufficient, and convalescent plasma have been used in caring for patients.

The health system is also participating in large clinical trials to better understand the latest treatment options.

This milestone comes as Geisinger begins consolidating its COVID treatment areas and begins offering more services that were paused during the pandemic.

With declining numbers of new positive cases locally, the health system is gradually returning services and reopening clinics with extra safety precautions and measures to stop the spread of the virus in the community.

To learn more about how Geisinger is safely caring for its patients, visit Geisinger.org/safe.


Today's breaking news and more in your inbox

I'm interested in (please check all that apply)